The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FLORA-5: Front-line chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab [PCO] versus chemotherapy (Paclitaxel-Carboplatin-Placebo [PCP]) in patients with advanced epithelial ovarian cancer (EOC)—Phase III double-blind placebo controlled multinational study.
 
Angeles Alvarez Secord
Honoraria - Aravive; Clovis Oncology; Eisai; Merck; Myriad Genetics; Tesaro/GSK
Consulting or Advisory Role - Aravive; Clovis Oncology; Eisai; Merck; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immutep (Inst); Merck (Inst); OncoQuest Pharmaceuticals (Inst); PharmaMar (Inst); Seagen (Inst); Tesaro (Inst); VBL Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - GOG Foundation; OncoQuest Pharmaceuticals; Roche/Genentech; VBL Therapeutics
 
Sunil Gupta
Employment - Agenus; OncoQuest Pharmaceuticals
Leadership - Agenus
Stock and Other Ownership Interests - Agenus; Sanofi
Patents, Royalties, Other Intellectual Property - I received 3 patents on method of use for cabazitaxel (Jevtana( for patients with mCRPC who have been previously treated with docetaxel while employed with Sanofi Inc. The rights to the patients were transferred to Sanofi and I receive no compensation or
Travel, Accommodations, Expenses - Agenus
 
Cathy Reddick
Employment - OncoQuest Pharmaceuticals
 
Jyoti Chauhan
Employment - OncoQuest
 
Sarah Gill
No Relationships to Disclose
 
John O. Schorge
No Relationships to Disclose
 
Michael Gold
No Relationships to Disclose
 
Devansu Tewari
No Relationships to Disclose
 
Christopher A Breed
No Relationships to Disclose
 
Patricia S. Braly
Consulting or Advisory Role - Seagen
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
 
Dennis Yi-Shin Kuo
No Relationships to Disclose
 
Susan C. Modesitt
Research Funding - Merck (Inst); Tesaro (Inst)
 
Robert W. Holloway
Consulting or Advisory Role - Abbvie; Clovis Oncology
Speakers' Bureau - AstraZeneca; Bard/Davol; Clovis Oncology; Tesaro